Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Metabolic interactions with statins].

E Molden1, A Asberg

  • 1Avdeling for farmakologi Farmasøytisk institutt Universitetet i Oslo Postboks 1068 Blindern 0316 Oslo. espen.molden@farmasi.uio.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|July 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eelgrass (Zostera marina L.) populations are threatened by high sea-surface temperatures and impaired waters on Nantucket Island, USA.

Marine pollution bulletin·2023
Same author

T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol.

Leukemia·2019
Same author

The EKiTE network (epidemiology in kidney transplantation - a European validated database): an initiative epidemiological and translational European collaborative research.

BMC nephrology·2019
Same author

Contraceptive Choices and Counseling in Norwegian Female Renal Transplant Recipients.

Transplantation proceedings·2019
Same author

Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.

Leukemia·2017
Same author

Outcomes in Pancreas Transplantation With Exocrine Drainage Through a Duodenoduodenostomy Versus Duodenojejunostomy.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017

The cytochrome P450 (CYP) system significantly impacts statin drug metabolism. Simvastatin and lovastatin exhibit the highest risk for drug interactions due to CYP3A4 metabolism.

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Biochemistry

Context:

  • Cytochrome P450 (CYP) enzymes are crucial for metabolizing drugs, including HMG-CoA reductase inhibitors (statins).
  • Understanding statin metabolism is vital for assessing and preventing drug-drug interactions.

Purpose:

  • To review the metabolic pathways of statins and evaluate their potential for drug interactions.
  • To identify statins with a higher risk of interactions based on their metabolic profiles.

Summary:

  • CYP3A4 is responsible for over 50% of drug metabolism and is the primary elimination route for simvastatin, lovastatin, and atorvastatin.
  • Simvastatin and lovastatin show the highest potential for clinically significant interactions via CYP3A4, often increasing efficacy or toxicity.
  • Pravastatin, cerivastatin, and fluvastatin have lower interaction potential through CYP3A4, though fluvastatin may interact via CYP2C9.

Related Experiment Videos

Impact:

  • Highlights the importance of considering drug interaction risks when prescribing statins, especially in patients on long-term, multiple-drug therapies.
  • Informs clinical decision-making for statin selection to minimize adverse events and optimize therapeutic outcomes.